Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 268

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 268
---
 ​            |        — |   | ​          |       — |   | ​           |    -891,382 |   | ​             |    -891,382 |
| Balance - March 31, 2025                                              |   |    6,900,000 | ​ | $      | 690 | ​ | $            | -192,083 | ​ | $          |  45,616 | ​ | $           | -18,416,581 | ​ | $             | -18,562,358 |

| ​                                                                     
 ​                                                                     
 ​                                                                     
 ​                                                                     
 ​                                                                     | ​ 
 ​ 
 ​ 
 ​ |            ​ 
 Common Stock 
      Class A 
            ​ 
       Shares | ​ 
 ​ | ​      
 ​      
 Amount |   ​ 
   ​ | ​ 
 ​ 
 ​ 
 ​ | ​            
 Extension    
 deposits due 
 from         
 Sponsor      | ​ | ​ 
 ​ 
 ​ 
 ​ | ​          
 ​          
 Additional 
 Paid-in    
 Capital    |       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​           
 ​           
 Accumulated 
 Deficit     |           ​ 
           ​ 
           ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 ​             
 Total         
 Stockholders’ 
 Deficit       |           ​ 
           ​ |
|:----------------------------------------------------------------------|:--|-------------:|:--|:-------|----:|:--|:-------------|:--|:--|:-----------|--------:|:--|:------------|------------:|:--|:--------------|------------:|
| Balance as of January 1, 2024                                         |   |    6,900,000 | ​ | $      | 690 | ​ | $            | — | ​ | $          | 140,000 | ​ | $           | -14,883,124 | ​ | $             | -14,742,434 |
| Remeasurement of Class A common stock to redemption amount            |   |            — | ​ |        |   — | ​ |              | — | ​ |            | -86,389 | ​ |             |           — | ​ |               |     -86,389 |
| Excise tax payable attributable to redemption of Class A common stock |   |            — | ​ |        |   — | ​ |              | — | ​ |            |       — | ​ |             |     -12,657 | ​ |               |     -12